- Pharmaceutical composition for preventing or treating hematoposis disorder diseases comprising maghemite-saponins nanoparticles

摘要

The present invention relates to a composition for treating hematopoietic dysfunction comprising a maghemite-saponin nanoconjugate as an active ingredient, wherein the maghemite-saponin nanoconjugate improves red blood cell reduction in anemia due to iron deficiency, chemicals or The maghemite-saponin nanoconjugates are associated with hematopoietic dysfunction, confirming that the number of erythrocytes, leukocytes, platelets, or neutrophil granulocytes in animal models showing hematopoietic deterioration such as hematopoiesis decrease by radiation treatment is restored to normal levels. It may be provided as a composition for preventing or treating a disease, and may be combined with a chemical or radiation therapy.